Strain-Specific Spontaneous and NNK-Mediated Tumorigenesis in Pten+/− Mice

by Mary Christine Hollander, Andria R. Balogh, Jaminelli Liwanag, Wei Han, Ritva Ilona Linnoila, Miriam R. Anver, Phillip A. Dennis
Published 2008-08-01

A novel classification of lung cancer into molecular subtypes.

by Lisandra West, Smruti J Vidwans, Nicholas P Campbell, Jeff Shrager, George R Simon, Raphael Bueno, Phillip A Dennis, Gregory A Otterson, Ravi Salgia
Published 2012-01-01

Assessing the Influence of Subsequent Immunotherapy on Overall Survival in Patients with Unresectable Stage III Non–Small Cell Lung Cancer from the PACIFIC Study

by Mario Ouwens, PhD, Annie Darilay, PhD, Yiduo Zhang, PhD, Pralay Mukhopadhyay, PhD, Helen Mann, MSc, James Ryan, MSc, Phillip A. Dennis, MD
Published 2021-01-01

Rapamycin Prevents the Development and Progression of Mutant Epidermal Growth Factor Receptor Lung Tumors with the Acquired Resistance Mutation T790M

by Shigeru Kawabata, José R. Mercado-Matos, M. Christine Hollander, Danielle Donahue, Willie Wilson III, Lucia Regales, Mohit Butaney, William Pao, Kwok-Kin Wong, Pasi A. Jänne, Phillip A. Dennis
Published 2014-06-01

Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistance.

by Chunyu Zhang, Abdel G Elkahloun, Matthew Robertson, Joell J Gills, Junji Tsurutani, Joanna H Shih, Junya Fukuoka, M Christine Hollander, Curtis C Harris, William D Travis, Jin Jen, Phillip A Dennis
Published 2011-01-01

A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesis.

by Courtney A Granville, Regan M Memmott, Andria Balogh, Jacopo Mariotti, Shigeru Kawabata, Wei Han, Jaclyn Lopiccolo, Jason Foley, David J Liewehr, Seth M Steinberg, Daniel H Fowler, M Christine Hollander, Phillip A Dennis
Published 2009-01-01